COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients
NCT04474340
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
300
Enrollment
OTHER_GOV
Sponsor class
Conditions
Moderate COVID-19 Pneumonia, Severe COVID-19 Pneumonia
Pneumonia, Viral
Interventions
DRUG:
COVID-19 Convalscent Plasma
Sponsor
Ministry of Health, Kuwait